16 September 2026 note archive · Item
Islet autoantibody screening (GADA, IA-2A, ZnT8A, IAA): review notes
These archived notes document the scope reviewed on 16 September, including source-access limits. They do not cover later changes or newly added records. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Preventing and curing evidence review — 16 September 2026
- Disposition: corrected/updated. Current item
lastReviewed: 2026-09-16. - Claim check: Added 10 September 2026 peer-reviewed general-population consensus with ages 2–4, 6–8, 10–15 and required follow-up. Primary full text disagrees with convening-body announcement on middle age band (announcement 4–6); used 6–8. Historical staging/progression and assay-standardization evidence retained.
- Primary publication/regulatory sources checked or consulted: s00125-026-06841-z; dc15-1419; jama.2013.6285; jama.2019.21565; s00125-023-05953-0; dc21-0422; dci24-0042; dc19-2003; j.ypmed.2026.108625; dom.70569; dc25-1326.